Reolysin: Completed Phase I enrollment

Oncolytics completed enrollment of 36 patients in the

Read the full 89 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE